Potential of Recombinant Human Growth Hormone in HIV-Associated Adipose Redistribution Syndrome

ISSN： 1173-8804

Source： BioDrugs, Vol.14, Iss.2, 2000-08, pp. : 83-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human Growth Hormone: Rationale for Use in the Treatment of HIV-Associated Lipodystrophy

By Benedini Stefano

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite

Recombinant Human Thyroid-Stimulating Hormone: Pharmacology, Clinical Applications and Potential Uses

By Emerson C.H. Torres M.S.T.

BioDrugs, Vol. 17, Iss. 1, 2003-01 ,pp. : 19-38

Adis International

Access to resources Recommend Favorite

HIV-Associated Pruritus: Etiology and Management

By Singh F. Rudikoff D.

American Journal of Clinical Dermatology, Vol. 4, Iss. 3, 2003-01 ,pp. : 177-188

Adis International

Access to resources Recommend Favorite

Spotlight on Tesamorelin in HIV-Associated Lipodystrophy†

By Dhillon Sohita

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 405-408

Adis International

Access to resources Recommend Favorite

Management Strategies for HIV-Associated Aphthous Stomatitis

By Kerr A.R. Ship J.A.

American Journal of Clinical Dermatology, Vol. 4, Iss. 10, 2003-01 ,pp. : 669-680

Adis International

Access to resources Recommend Favorite